Camrelizumab group:Nil

2 trials

Sponsors

West China Hospital of Sichuan University, The First Affiliated Hospital of Henan University of Science and Technology

Conditions

Advanced gastric cancer and colorectal cancerHepatocellular carcinoma

Phase 4

Observation research on the efficacy and safety of Camrelizumab in the treatment of advanced gastric cancer and colorectal cancer

RecruitingChiCTR2100051186

The First Affiliated Hospital of Henan University of Science and TechnologyAdvanced gastric cancer and colorectal cancer

Start: 2021-09-30Updated: 2022-05-23

Unknown Phase

A prospective multicenter study of hepatocellular carcinoma treated with Camrelizumab

RecruitingChiCTR2100046854

West China Hospital of Sichuan UniversityHepatocellular carcinoma

Start: 2021-05-28Updated: 2022-01-10